Vivos Therapeutics holder reports 0.6% passive stake

Vivos Therapeutics, Inc. (VVOS) is reported to have 122,963 shares of its common stock beneficially owned by Streeterville Capital LLC, with Streeterville Management LLC and John M. Fife reporting indirect beneficial ownership.

Rhea-AI Filing Summary

Vivos Therapeutics, Inc. (VVOS) is reported to have 122,963 shares of its common stock beneficially owned by Streeterville Capital LLC, with Streeterville Management LLC and John M. Fife reporting indirect beneficial ownership. This position represents 0.6% of the common stock, based on 20,118,023 shares outstanding as of August 13, 2026. Streeterville Capital LLC, Streeterville Management LLC, and John M. Fife each report sole voting and dispositive power over 122,963 shares and no shared voting or dispositive power. The reporting group states that it holds 5 percent or less of the class of VVOS common stock.

Key Figures

Shares beneficially owned: 122,963 shares Ownership percentage: 0.6% Shares outstanding: 20,118,023 shares +2 more

5 metrics

Shares beneficially owned 122,963 shares Common stock of Vivos Therapeutics beneficially owned by Streeterville Capital LLC

Ownership percentage 0.6% Percent of VVOS common stock beneficially owned by the reporting persons

Shares outstanding 20,118,023 shares VVOS common stock outstanding as of August 13, 2026, used to calculate ownership

Sole voting power 122,963 shares Shares over which each reporting person has sole voting power

Sole dispositive power 122,963 shares Shares over which each reporting person has sole dispositive power

Key Terms

beneficially owned, sole voting power, sole dispositive power, Ownership of 5 percent or less of a class

4 terms

beneficially owned financial

"with respect to the shares of common stock of the Issuer that are directly beneficially owned"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole voting power financial

"Sole Voting Power 122,963.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"Sole Dispositive Power 122,963.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Ownership of 5 percent or less of a class financial

"Item 5. | Ownership of 5 Percent or Less of a Class."

FAQ

What percentage of Vivos Therapeutics (VVOS) does Streeterville Capital report owning?

Streeterville Capital LLC, together with Streeterville Management LLC and John M. Fife, reports beneficial ownership of 0.6% of Vivos Therapeutics’ common stock, based on 20,118,023 shares outstanding as of August 13, 2026.

How many VVOS shares are beneficially owned by Streeterville Capital and affiliates?

Streeterville Capital LLC, with Streeterville Management LLC and John M. Fife as additional reporting persons, reports beneficial ownership of 122,963 shares of Vivos Therapeutics common stock, with sole voting and dispositive power over all of these shares.

Who are the reporting persons for the Vivos Therapeutics (VVOS) Schedule 13G/A?

The reporting persons are Streeterville Capital LLC, Streeterville Management LLC, and John M. Fife. The shares are directly beneficially owned by Streeterville Capital LLC and indirectly beneficially owned by Streeterville Management LLC and John M. Fife.

What is the share count used to calculate Streeterville’s 0.6% ownership in VVOS?

The 0.6% ownership figure is calculated based on 20,118,023 shares of Vivos Therapeutics common stock outstanding as of August 13, 2026, as reported in the company’s Form 10-Q filed on August 14, 2026.

Does Streeterville Capital report shared voting or dispositive power over VVOS shares?

No. Streeterville Capital LLC, Streeterville Management LLC, and John M. Fife each report sole voting power over 122,963 shares and sole dispositive power over 122,963 shares, with no shared voting or dispositive power.

Is the Streeterville Capital group a 5% or greater holder of VVOS common stock?

No. The reporting persons state under “Ownership of 5 Percent or Less of a Class” that they beneficially own 5 percent or less of Vivos Therapeutics’ common stock, specifically 0.6% of the class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 05:00 PM Accepted by SEC EDGAR 09/03/2026 - 04:48 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Vivos Therapeutics, Inc.

(Name of Issuer)

Common stock, par value $0.0001 per share

(Title of Class of Securities)

92859E207

(CUSIP Number)

09/03/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 92859E207

1

Names of Reporting Persons

Streeterville Capital LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UTAH

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 122,963.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 122,963.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

122,963.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.6 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Based on 20,118,023 shares outstanding as of August 13, 2026 as reported in Issuer's 10-Q filed on August 14, 2026.

SCHEDULE 13G

CUSIP Number(s): 92859E207

1

Names of Reporting Persons

Streeterville Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UTAH

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 122,963.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 122,963.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

122,963.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.6 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Based on 20,118,023 shares outstanding as of August 13, 2026 as reported in Issuer's 10-Q filed on August 14, 2026.

SCHEDULE 13G

CUSIP Number(s): 92859E207

1

Names of Reporting Persons

John M Fife

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 122,963.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 122,963.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

122,963.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.6 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Based on 20,118,023 shares outstanding as of August 13, 2026 as reported in Issuer's 10-Q filed on August 14, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Vivos Therapeutics, Inc.
(b)	Address of issuer's principal executive offices: 7921 SOUTHPARK PLAZA,, SUITE 210, LITTLETON, COLORADO, 80120
Item 2.
(a)	Name of person filing: This report is filed by Streeterville Capital LLC, Streeterville Management LLC, and John M. Fife with respect to the shares of common stock of the Issuer that are directly beneficially owned by Streeterville Capital LLC and indirectly beneficially owned by the other reporting and filing persons.
(b)	Address or principal business office or, if none, residence: 300 East Randolph Street, Suite 40.150 Chicago, IL 60601
(c)	Citizenship: Streeterville Capital LLC is a Utah limited liability company. Streeterville Management LLC is a Utah limited liability company. John M. Fife is a United States citizen.
(d)	Title of class of securities: Common stock, par value $0.0001 per share
(e)	CUSIP No.: 92859E207
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 122,963
(b)	Percent of class: 0.6%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 122,963
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 122,963
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Streeterville Capital LLC

Signature:	John Fife
Name/Title:	President
Date:	09/03/2026

Streeterville Management, LLC

Signature:	John Fife
Name/Title:	President
Date:	09/03/2026

John M Fife

Signature:	John Fife
Name/Title:	John Fife
Date:	09/03/2026